Renal nerve ablation for resistant hypertension: the dust has not yet settled.
作者信息
Doumas Michael, Lazaridis Antonios, Papademetriou Vasilios
机构信息
VAMC, George Washington University, Washington, DC; Aristotle University, Thessaloniki, Greece.
出版信息
J Clin Hypertens (Greenwich). 2014 Jun;16(6):399-400. doi: 10.1111/jch.12324. Epub 2014 Apr 28.
Abstract
摘要
相似文献
1
Renal nerve ablation for resistant hypertension: the dust has not yet settled.肾神经消融术治疗顽固性高血压：尘埃尚未落定。
J Clin Hypertens (Greenwich). 2014 Jun;16(6):399-400. doi: 10.1111/jch.12324. Epub 2014 Apr 28.
2
Cochrane corner: renal denervation for resistant hypertension-a broken promise?考克兰视角：肾去神经术治疗顽固性高血压——一个破灭的承诺？
Heart. 2017 Nov;103(22):1753-1755. doi: 10.1136/heartjnl-2017-311584. Epub 2017 May 13.
3
Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.肾神经消融治疗顽固性高血压：我们是如何走到这一步的、现状及未来方向
Circulation. 2014 Apr 1;129(13):1440-51. doi: 10.1161/CIRCULATIONAHA.113.005405.
4
Renal Denervation-Ready for Prime Time!? The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment.肾去神经支配——准备好迎接黄金时代了吗？高血压治疗中通往辉煌的陡峭螺旋阶梯。
Hypertension. 2018 Aug;72(2):287-290. doi: 10.1161/HYPERTENSIONAHA.118.11532. Epub 2018 Jun 25.
5
Renal denervation in hypertension: Towards a true revival?高血压中的肾去神经支配：能否真正复兴？
Arch Cardiovasc Dis. 2018 Oct;111(10):541-544. doi: 10.1016/j.acvd.2018.08.001. Epub 2018 Sep 12.
6
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).通过24小时血压监测预测和评估肾去神经支配的影响：DENERHTN研究（肾去神经支配治疗高血压）
Hypertension. 2017 Mar;69(3):494-500. doi: 10.1161/HYPERTENSIONAHA.116.08448. Epub 2017 Jan 23.
7
Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.肾去神经支配对顽固性高血压患者动态血压测量的影响。
Clin Cardiol. 2014 May;37(5):307-11. doi: 10.1002/clc.22269. Epub 2014 Apr 2.
8
Hypertension: Further EnligHTNment on renal sympathetic denervation.高血压：肾交感神经去神经支配的进一步启示
Nat Rev Cardiol. 2013 Sep;10(9):490. doi: 10.1038/nrcardio.2013.104. Epub 2013 Jul 9.
9
Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.动态血压可被设定为肾去神经支配临床试验中的主要疗效指标。
Int J Cardiol. 2014 Oct 20;176(3):1262-3. doi: 10.1016/j.ijcard.2014.07.192. Epub 2014 Aug 4.
10
Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.难治性高血压与肾交感神经去神经支配：药物依从性及血压降低效果的巩固
EuroIntervention. 2013 May;9 Suppl R:R7-9. doi: 10.4244/EIJV9SRA1.
引用本文的文献
1
Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?肾交感神经去神经支配：尘归尘，还是浴火重生？
J Clin Hypertens (Greenwich). 2018 Apr;20(4):634-636. doi: 10.1111/jch.13261. Epub 2018 Mar 25.
本文引用的文献
1
Renal sympathetic denervation: early impact on ambulatory resistant hypertension.肾交感神经去神经支配：对动态顽固性高血压的早期影响。
J Clin Hypertens (Greenwich). 2014 Jun;16(6):406-11. doi: 10.1111/jch.12326. Epub 2014 Apr 28.
2
Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.药物和器械试验中降压效果预估的非故意夸大：机制与对策。
Int J Cardiol. 2014 Mar 1;172(1):29-35. doi: 10.1016/j.ijcard.2013.12.183. Epub 2014 Jan 8.
3
Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.动态阻力性高血压模式对心血管发病率的预测作用：一项为期 4 年的前瞻性研究。
J Hypertens. 2014 Feb;32(2):415-22. doi: 10.1097/HJH.0000000000000023.
4
Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis.采用毒理学血清分析对顽固性高血压患者抗高血压治疗不依从性进行精准评估。
J Hypertens. 2013 Dec;31(12):2455-61. doi: 10.1097/HJH.0b013e3283652c61.
5
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.经皮肾动脉去神经术治疗抗高血压药物抵抗的高血压患者：Symplicity HTN-1 研究的最终 3 年报告。
Lancet. 2014 Feb 15;383(9917):622-9. doi: 10.1016/S0140-6736(13)62192-3. Epub 2013 Nov 7.
6
Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report.降压幅度从肾去神经术：荟萃分析抗高血压药物试验 4121 例患者的见解，重点关注试验设计：CONVERGE 报告。
Heart. 2013 Nov;99(21):1579-87. doi: 10.1136/heartjnl-2013-304238. Epub 2013 Sep 15.
7
Renal nerve ablation for hypertensive patients with chronic kidney disease.慢性肾脏病高血压患者的肾神经消融术。
Curr Vasc Pharmacol. 2014 Jan;12(1):47-54. doi: 10.2174/15701611113119990143.
8
Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.多电极肾交感神经消融系统治疗抵抗性高血压的安全性和有效性：EnligHTN I 试验。
Eur Heart J. 2013 Jul;34(28):2132-40. doi: 10.1093/eurheartj/eht197. Epub 2013 Jun 19.
9
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.肾神经去交感神经术治疗抵抗性高血压患者后的动态血压变化。
Circulation. 2013 Jul 9;128(2):132-40. doi: 10.1161/CIRCULATIONAHA.112.000949. Epub 2013 Jun 18.
10
Resistant hypertension? Assessment of adherence by toxicological urine analysis.耐药性高血压？毒理学尿液分析评估依从性。
J Hypertens. 2013 Apr;31(4):766-74. doi: 10.1097/HJH.0b013e32835e2286.
Zotero 插件